Emei Tongde Pharmaceutical

Sichuan Emeishan Tongde Pharmaceutical Co., Ltd., known as Emei Tongde, is a Chinese pharmaceutical company specializing in the research, development, and production of Traditional Chinese Medicine (TCM) and chemical drugs. A key subsidiary of Tibet Rhodiola Pharmaceutical Holding, the company operates modern, GMP-certified manufacturing facilities in Emeishan City, Sichuan Province. Its therapeutic focus is primarily on cardiovascular and cerebrovascular health, with a product portfolio that includes flagship items such as Shuxuening Injection and various herbal extracts. Emei Tongde is recognized for its efforts in the modernization of TCM, integrating traditional herbal knowledge with standardized industrial manufacturing processes to serve the domestic Chinese market.